Cargando…

High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome

BACKGROUND: A promising biomarker for axonal damage early in the disease course of multiple sclerosis (MS) is neurofilament light chain (NfL). It is unknown whether NfL has the same predictive value for MS diagnosis in children as in adults. OBJECTIVE: To explore the predictive value of NfL levels i...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Vuurst de Vries, Roos M, Wong, Yu Yi M, Mescheriakova, Julia Y, van Pelt, E Daniëlle, Runia, Tessel F, Jafari, Naghmeh, Siepman, Theodora AM, Melief, Marie-José, Wierenga-Wolf, Annet F, van Luijn, Marvin M, Samijn, Johnny P, Neuteboom, Rinze F, Hintzen, Rogier Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545618/ https://www.ncbi.nlm.nih.gov/pubmed/29774770 http://dx.doi.org/10.1177/1352458518775303

Ejemplares similares

Smoking at time of CIS increases the risk of clinically definite multiple sclerosis
por: van der Vuurst de Vries, Roos M., et al.
Publicado: (2018)

Fatigue after a first attack of suspected multiple sclerosis
por: van der Vuurst de Vries, Roos M, et al.
Publicado: (2017)

T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes
por: Wong, Yu Yi M, et al.
Publicado: (2018)

Pregnancy-induced effects on memory B-cell development in multiple sclerosis
por: Janssen, Malou, et al.
Publicado: (2021)

Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis
por: van Langelaar, Jamie, et al.
Publicado: (2019)

The association of Epstein‐Barr virus infection with CXCR3(+) B‐cell development in multiple sclerosis: impact of immunotherapies
por: van Langelaar, Jamie, et al.
Publicado: (2020)

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis
por: Rijvers, Liza, et al.
Publicado: (2018)

Real-world validation of the 2017 McDonald criteria for pediatric MS
por: Wong, Yu Yi M., et al.
Publicado: (2018)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2021)

Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis
por: Toussaint-Duyster, Leontien CC, et al.
Publicado: (2017)

Gray matter–related proteins are associated with childhood-onset multiple sclerosis
por: Singh, Vaibhav, et al.
Publicado: (2015)

Brain-homing CD4(+) T cells display glucocorticoid-resistant features in MS
por: Koetzier, Steven C., et al.
Publicado: (2020)

Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry
por: Siepman, Theodora A. M., et al.
Publicado: (2010)

Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses
por: Janssen, Malou, et al.
Publicado: (2020)

Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
por: Kreft, Karim L, et al.
Publicado: (2014)

Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: About one in a million
por: Daniëlle van Pelt, E, et al.
Publicado: (2016)

HLA association in MOG-IgG– and AQP4-IgG–related disorders of the CNS in the Dutch population
por: Bruijstens, Arlette L., et al.
Publicado: (2020)

Improving Glucocorticoid Sensitivity of Brain-Homing CD4(+) T Helper Cells by Steroid Hormone Crosstalk
por: Koetzier, Steven C., et al.
Publicado: (2022)

Pregnancy in multiple sclerosis: clinical and self-report scales
por: Neuteboom, R. F., et al.
Publicado: (2011)

Distinct Effector Programs of Brain-Homing CD8(+) T Cells in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2022)

Burden of genetic risk variants in multiple sclerosis families in the Netherlands
por: Mescheriakova, Julia Y, et al.
Publicado: (2016)

Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
por: Bruinsma, Ilona B., et al.
Publicado: (2017)

Multiple sclerosis risk variants influence the peripheral B‐cell compartment early in life in the general population
por: de Mol, Casper L., et al.
Publicado: (2022)

Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients
por: van Nierop, Gijsbert P., et al.
Publicado: (2017)

EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution
por: Mescheriakova, Julia Y., et al.
Publicado: (2020)

Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family
por: Mescheriakova, Julia Y, et al.
Publicado: (2018)

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis
por: Brenner, Juliette, et al.
Publicado: (2023)

Pediatric autoimmune encephalitis: Recognition and diagnosis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2020)

Selective emergence of antibody-secreting cells in the multiple sclerosis brain
por: Bogers, Laurens, et al.
Publicado: (2023)

T cell composition and polygenic multiple sclerosis risk: A population‐based study in children
por: de Mol, Casper L., et al.
Publicado: (2021)

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
por: Ghezzi, Angelo, et al.
Publicado: (2023)

Human T-bet(+) B cell development is associated with BTK activity and suppressed by evobrutinib
por: Rijvers, Liza, et al.
Publicado: (2022)

Polygenic Multiple Sclerosis Risk and Population‐Based Childhood Brain Imaging
por: de Mol, C. Louk, et al.
Publicado: (2020)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Neurofilaments contribution in clinic: state of the art
por: Delaby, Constance, et al.
Publicado: (2022)

Neuronal antibodies in pediatric epilepsy: Clinical features and long‐term outcomes of a historical cohort not treated with immunotherapy
por: Wright, Sukhvir, et al.
Publicado: (2016)

Perspectives on the Use of Multiple Sclerosis Risk Genes for Prediction
por: Jafari, Naghmeh, et al.
Publicado: (2011)

Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)
por: Jongen, Peter J, et al.
Publicado: (2011)

Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment
por: Bruijstens, Arlette L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6793nvfqc0c9jj4k335adi4ghf